NIAID PROFESSIONAL, SCIENTIFIC AND TECHNICAL SUPPORT SERVICES (PSTSS)
ID: 75N93023R00010Type: Sources Sought
Overview

Buyer

HEALTH AND HUMAN SERVICES, DEPARTMENT OFNATIONAL INSTITUTES OF HEALTHNATIONAL INSTITUTES OF HEALTH NIAIDBETHESDA, MD, 20892, USA

PSC

SUPPORT- MANAGEMENT: CONTRACT/PROCUREMENT/ACQUISITION SUPPORT (R707)

Original Source

https://sam.gov/opp/2f7b4b2400ca4a5c875a19a3b3fc0bf7/view
Timeline
    Description

    The Department of Health and Human Services, through the National Institutes of Health (NIH) and specifically the National Institute of Allergy and Infectious Diseases (NIAID), is issuing a presolicitation notice for professional, scientific, and technical support services under RFP number 75N93023R00010. This procurement aims to secure a re-competition of existing contracts to support NIAID's mission in research, vaccine development, and management of infectious diseases, with key tasks including laboratory support, clinical trials, and consultancy in various scientific specialties. The anticipated contract duration is five years, commencing on June 1, 2025, with proposals expected to be submitted electronically after the RFP release around October 24, 2024. Interested vendors should contact Rosemary Gomes at Rosemary.Gomes@nih.gov or Kristel Turansky at Kristel.Turansky@nih.gov for further information.

    Files
    Title
    Posted
    Presolicitation Notice 10.03.2024.pdf
    The National Institute of Allergy and Infectious Diseases (NIAID) is issuing a presolicitation notice for the Request for Proposals (RFP) number 75N93023R00010, aimed at securing professional, scientific, and technical support services. This contract will be a re-competition of several existing contracts and will focus on addressing NIAID's mission to conduct research, support vaccine development, and manage infectious disease challenges. The anticipated contract duration is five years, starting from June 1, 2025, with service locations primarily in Maryland and potentially elsewhere in the U.S. and internationally. Key tasks include laboratory support, clinical trials, and consultancy in various scientific specialties, particularly related to infectious diseases and immune-mediated disorders. Vendors must provide highly specialized personnel capable of operating in complex environments, including high-containment laboratories. The RFP emphasizes the need for meticulous record-keeping and the ability to manage high-volume, time-sensitive tasks. Proposals will be evaluated based on the ability to deliver qualified personnel and support across a wide range of scientific disciplines critical to NIAID's research initiatives. The RFP will be available around October 24, 2024, and proposals must be submitted electronically.
    Sources Sought Notice.pdf
    Similar Opportunities
    NIAID CLINICAL PRODUCTS CENTER (CPC)
    Active
    Health And Human Services, Department Of
    The Department of Health and Human Services, through the National Institutes of Health (NIH) and specifically the National Institute of Allergy and Infectious Diseases (NIAID), is seeking proposals for the NIAID Clinical Products Center (CPC) contract, aimed at supporting clinical trials focused on immunologic, infectious, and allergic diseases. The contract will provide essential pharmacy and pharmaceutical oversight for national and international clinical trials, ensuring product integrity, participant safety, and compliance with regulatory standards, while also expanding support for additional NIH-funded trials and emergency public health programs as needed. This initiative is critical for advancing research in various immune-mediated diseases, including asthma, autoimmune disorders, and organ transplant rejection. Interested parties should prepare to submit proposals electronically via the NIAID electronic Contract Proposal Submission (eCPS) website, with the presolicitation notice expected to be published on or around October 18, 2024. For further inquiries, contact Deborah Blyveis at blyveisd@niaid.nih.gov or Emily Bannister at emily.bannister@nih.gov.
    PREPARATION AND DISTRIBUTION OF RESEARCH DRUG PRODUCTS
    Active
    Health And Human Services, Department Of
    The Department of Health and Human Services, specifically the National Institutes of Health (NIH) through the National Institute on Drug Abuse (NIDA), is seeking proposals for the "Preparation and Distribution of Research Drug Products" under Request for Proposal (RFP) No. 75N95024R00003. The primary objective of this procurement is to acquire, analyze, create, regulate, and distribute a variety of drug compounds essential for advancing research on drug abuse and addiction, including controlled and uncontrolled substances such as morphine, methadone, and various cannabinoid preparations. This contract, structured as an indefinite delivery, indefinite quantity (IDIQ) agreement for a five-year period, is crucial for supporting the drug abuse research community by ensuring the availability of authentic drug products while adhering to federal regulations. Proposals must be submitted electronically by November 15, 2024, and interested parties can contact Scott Duernberger at scott.duernberger@nih.gov or Josh Lazarus at josh.lazarus@nih.gov for further information.
    A--Request for Proposals - Phase I Clinical Trials
    Active
    Health And Human Services, Department Of
    The Department of Health and Human Services, through the National Institutes of Health (NIH), is soliciting proposals for Phase I Clinical Trials focused on the development of small molecule and biologics therapeutics. The objective is to engage qualified contractors to conduct comprehensive clinical trials, including protocol development, trial management, and reporting to regulatory agencies, with a specific emphasis on safety, tolerability, and pharmacokinetics of investigational drugs. This initiative is crucial for advancing therapeutic development in neurological disorders and ensuring compliance with federal regulations regarding human subjects. Proposals are due by October 11, 2024, with a contract performance period extending from April 1, 2025, to March 31, 2035, and a maximum contract value of $233,227,446. For further inquiries, interested parties may contact Evan C. Feely at evan.feely@nih.gov or +1 301 827 5301.
    IMMUNE EPITOPE DATABASE AND ANALYSIS PROGRAM
    Active
    Health And Human Services, Department Of
    The Department of Health and Human Services, specifically the National Institutes of Health (NIH), is soliciting proposals for the Immune Epitope Database and Analysis Program, aimed at enhancing research capabilities related to infectious diseases, allergies, and autoimmunity. The program seeks to provide a comprehensive resource for researchers to explore data on antibody and T-cell epitopes, with a focus on maintaining high standards of compliance and transparency in research practices. Proposals are due by November 19, 2024, with a base performance period from October 15, 2025, to October 14, 2026, and potential extensions for up to four additional years. Interested parties can contact Brandon de White at whitebra@niaid.nih.gov or Tom Bahrami at bahramit@niaid.nih.gov for further information.
    Scientific Management and Support to the National Institute of Mental Health (NIMH) Repository and Genomics Resource (NRGR)
    Active
    Health And Human Services, Department Of
    The Department of Health and Human Services, through the National Institute of Mental Health (NIMH), is seeking proposals for scientific management and support services for the National Institute of Mental Health Repository and Genomics Resource (NRGR). The primary objective of this procurement is to sustain, enhance, and enrich the NRGR, which provides critical biospecimens and associated data for research on psychiatric disorders, thereby facilitating genetic and cellular studies. This initiative is vital for advancing scientific understanding of the genetic risk factors and biological mechanisms underlying mental health conditions. Proposals are due by October 21, 2024, with the contract expected to commence on March 1, 2025, and run for a base period of one year, followed by four optional extension periods. Interested parties can direct inquiries to Sarah Adan at sarah.adan@nih.gov or Valerie Whipple at valerie.whipple@nih.gov.
    A Solicitation of the National Institutes of Health (NIH) and The Centers for Disease Control and Prevention (CDC) for Small Business Innovation Research (SBIR) Contract Proposals
    Active
    Health And Human Services, Department Of
    The National Institutes of Health (NIH) and the Centers for Disease Control and Prevention (CDC) are soliciting proposals from small businesses for the Small Business Innovation Research (SBIR) program, aimed at fostering innovative research that aligns with their mission needs. This solicitation, identified as PHS-2025-1, invites proposals across a wide range of health-related topics, including cancer research, aging, infectious diseases, and mental health, with the goal of stimulating technological innovation and enhancing commercialization in the healthcare sector. Eligible small businesses are encouraged to demonstrate the technical feasibility and commercial potential of their projects, with a closing date for proposal submissions set for October 18, 2024. For further inquiries, interested parties can contact Callie Prassinos at Callie.Prassinos@NIH.gov or Julie Rodriguez at ncioasbir@mail.nih.gov.
    A--BPCA Pediatric Trials Network
    Active
    Health And Human Services, Department Of
    The Department of Health and Human Services, through the National Institutes of Health (NIH), is soliciting proposals for an Indefinite Quantity Contract to establish and maintain an infrastructure for conducting pediatric clinical trials under the Best Pharmaceuticals for Children Act (BPCA). The primary objective of this procurement is to advance pediatric drug development by ensuring compliance with federal regulations and ethical standards in clinical research, including the protection of human subjects and quality control measures. This initiative is crucial for enhancing the understanding and safety of medications for children, thereby improving healthcare outcomes in pediatric populations. Proposals are due by November 4, 2024, with a performance period extending from May 19, 2025, to May 18, 2033, and a funding range between $2,500 and $149 million, contingent on successful contract performance. Interested parties can contact Elizabeth J. Osinski at eo43m@nih.gov or by phone at 240-550-5028 for further information.
    Rapid Pandemic Influenza and Emergency Infectious Disease Vaccine Development and Response Capability
    Active
    Health And Human Services, Department Of
    The Department of Health and Human Services, specifically the Office of Assistant Secretary for Preparedness and Response (BARDA), is seeking proposals for the "Rapid Pandemic Influenza and Emergency Infectious Disease Vaccine Development and Response Capability" through a Special Notice. The objective of this procurement is to establish a long-term partnership focused on developing a flexible and rapid response capability for vaccine development against pandemic influenza and other priority pathogens, initially emphasizing influenza mRNA vaccine development. This initiative is critical for enhancing the nation's preparedness and response to emerging infectious diseases, ensuring readiness to pivot quickly in the face of public health threats. Interested parties can access the full Request for Project Proposals and additional consortium information at www.rrpv.org, and inquiries can be directed to Rebecca Harmon at rebecca.harmon@ati.org.
    Notice of Intent One-Year Premium Service Contract for Aurora 4 Cytometer with Loader
    Active
    Health And Human Services, Department Of
    The National Institutes of Health (NIH), specifically the National Institute of Allergy and Infectious Diseases (NIAID), intends to negotiate a sole source Premium Maintenance Service Contract with Cytek Biosciences for the Aurora 4 Laser system. This contract, effective from October 15, 2024, to October 14, 2025, encompasses comprehensive service provisions, including preventive maintenance inspections, on-site support, and technical assistance, all requiring the use of original equipment manufacturer (OEM) specified parts and services. Interested vendors must submit a capability statement and relevant contracts by 10:00 AM on October 11, 2024, via the NIAID electronic Simplified Acquisition Submission System (eSASS) to be considered for this opportunity. For further inquiries, vendors can contact Leah Hinson at leah.hinson@nih.gov.
    Notice of Intent - Renewal Maintenance Services for MILabs VECTor at the Integrated Research Facility (IRF) at Fort Detrick, Maryland
    Active
    Health And Human Services, Department Of
    The Department of Health and Human Services, specifically the National Institutes of Health (NIH), intends to award a sole source contract for renewal maintenance services for the MILabs VECTor imaging equipment at the Integrated Research Facility (IRF) in Fort Detrick, Maryland. The contract will cover preventative and remedial maintenance, ensuring the equipment operates within the stringent requirements of a BSL-4 containment environment, which is critical for high-level biological research. The anticipated period of performance includes one base year from November 1, 2024, to October 31, 2025, with four additional one-year option periods, and interested vendors may submit their capabilities statements to Danielle Tines at danielle.tines@nih.gov within 15 days of this notice. The NAICS code for this acquisition is 811210, and the estimated contract value is not disclosed.